Welcome to our dedicated page for MetLife SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MetLife, Inc. filings document the regulatory record of a Delaware financial services company with NYSE-listed common stock and preferred securities, including depositary shares tied to Series E and Series F preferred stock. Recent Form 8-K reports furnish earnings releases, quarterly financial supplements, total assets under management fact sheets and Regulation FD disclosures related to variable investment income.
The filings also cover capital-structure actions such as subordinated debenture issuance and preferred stock dividend declarations. Proxy materials describe board composition, committee assignments, executive compensation and shareholder voting matters, while material-event reports record governance changes and other corporate disclosures.
MetLife, Inc. filed a Form 144 reporting intended sales of Common Stock, listing multiple small blocks sold in March–April 2026. The filing shows an entry of 725 shares on 03/02/2026 and several other lots (for example, 145 shares on 03/20/2026 and 121 shares on 04/02/2026).
MetLife, Inc. declared second quarter 2026 dividends on three series of preferred stock. The quarterly dividend is $0.31190376 per share on its floating rate non-cumulative preferred stock, Series A, which has a $25 per share liquidation preference.
Holders of the 5.625% non-cumulative preferred stock, Series E, will receive $351.5625 per share, equal to $0.3515625 per depositary share, based on a $25,000 per share liquidation preference. The 4.75% non-cumulative preferred stock, Series F, will pay $296.875 per share, or $0.296875 per depositary share, also on a $25,000 liquidation preference.
All these preferred dividends are payable on June 15, 2026, to shareholders of record as of May 29, 2026.
MetLife Inc. filed a Form 13F-HR reporting holdings on behalf of its investment management subsidiaries. The filing states a Form 13F Information Table Entry Total of 6 and a Form 13F Information Table Value Total of $12,335,766. The report is signed by John McCallion on 05-14-2026.
MetLife, Inc.’s board of directors, as an entity, reports beneficial ownership of 103,885,196 shares of common stock, representing 16.2% of the company’s outstanding shares as of April 30, 2026. These shares are held in the MetLife Policyholder Trust created under MetLife’s demutualization plan.
The board is deemed to beneficially own the trust shares because it directs how they are voted on most stockholder matters, while policyholder beneficiaries retain economic rights such as dividends and sale proceeds. Trust holdings have steadily declined from 494,466,664 shares issued to the trust in 2000, including a recent decrease from 105,374,380 shares to 103,885,196 shares due to beneficiary-related transactions.
MetLife reported solid Q1 2026 results with higher earnings and stable balance sheet strength. Total revenues were $19,074 million, up from $18,569 million a year earlier, driven by premiums of $12,120 million and net investment income of $5,355 million.
Net income attributable to MetLife, Inc. was $1,185 million versus $945 million, with net income available to common shareholders of $1,140 million compared to $879 million. Basic earnings per common share rose to $1.75 from $1.29, and diluted EPS increased to $1.74 from $1.28.
Total consolidated adjusted earnings across segments reached $1,631 million, up from $1,415 million, with particularly strong contributions from Asia, Group Benefits and RIS. Operating cash flow was $2,687 million, while MetLife returned capital through $372 million of common dividends and treasury stock repurchases of $762 million. The company ended the quarter with total assets of $743,211 million and total equity of $27,595 million, and continued integrating its Strategic Reorganization and the PineBridge Investments acquisition within the MIM segment.
MetLife, Inc. reported strong first quarter 2026 results with broad-based growth. Net income rose 30% to $1.14 billion, or $1.74 per share, while adjusted earnings increased 18% to $1.59 billion, or $2.42 per share, driven by higher variable investment income, volume growth and favorable underwriting.
Premiums, fees and other revenues grew 5% to $14.3 billion, and net investment income increased 10% to $5.36 billion. Segments delivered double‑digit adjusted earnings growth in Group Benefits, Retirement and Income Solutions, Asia, EMEA and MetLife Investment Management. Return on equity reached 18.2%, with adjusted ROE at 17.0%. MetLife returned over $1.1 billion to shareholders via dividends and buybacks, while book value per share rose to $37.92 and adjusted book value per share to $57.41.
MetLife, Inc. reported strong first quarter 2026 results with broad-based growth. Net income rose 30% to $1.14 billion, or $1.74 per share, while adjusted earnings increased 18% to $1.59 billion, or $2.42 per share, driven by higher variable investment income, volume growth and favorable underwriting.
Premiums, fees and other revenues grew 5% to $14.3 billion, and net investment income increased 10% to $5.36 billion. Segments delivered double‑digit adjusted earnings growth in Group Benefits, Retirement and Income Solutions, Asia, EMEA and MetLife Investment Management. Return on equity reached 18.2%, with adjusted ROE at 17.0%. MetLife returned over $1.1 billion to shareholders via dividends and buybacks, while book value per share rose to $37.92 and adjusted book value per share to $57.41.
MetLife submitted a Form 144 reporting proposed sales of Common Stock through Barclays. The filing lists recent transactions by plan/accounts, with sample dispositions including 725 shares on 03/02/2026 and 145 shares on 03/20/2026. The filing date shown is 05/05/2026.
MetLife Inc. EVP & Chief Accounting Officer Adrienne Karen O'Neill received a grant of 12,485 shares of Common Stock on April 30, 2026. The award is described as a restricted stock unit grant under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 27,042 shares.
MetLife Inc ownership filing shows Vanguard Capital Management beneficially owns 41,496,623 shares of Common Stock, representing 6.36% of the class as reported 03/31/2026. The filing states Vanguard has sole dispositive power over 41,496,623 shares and sole voting power for 5,639,806 shares.